AGE-RAGE synergy influences programmed cell death signaling to promote cancer

被引:74
作者
Waghela, Bhargav N. [1 ]
Vaidya, Foram U. [1 ]
Ranjan, Kishu [2 ]
Chhipa, Abu Sufiyan [1 ]
Tiwari, Budhi Sagar [1 ]
Pathak, Chandramani [1 ]
机构
[1] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Koba Inst Area, Cell Biol Lab, Gandhinagar 382426, Gujarat, India
[2] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06519 USA
关键词
AGEs; RAGE; AGE-RAGE signaling; Cell death; Cancer; GLYCATION END-PRODUCTS; BOVINE RETINAL PERICYTES; INDUCED APOPTOSIS; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; INDUCE APOPTOSIS; NADPH OXIDASE; IN-VITRO; TUMOR MICROENVIRONMENT; REGULATES AUTOPHAGY;
D O I
10.1007/s11010-020-03928-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Advanced glycation end products (AGEs) are formed as a result of non-enzymatic reaction between the free reducing sugars and proteins, lipids, or nucleic acids. AGEs are predominantly synthesized during chronic hyperglycemic conditions or aging. AGEs interact with their receptor RAGE and activate various sets of genes and proteins of the signal transduction pathway. Accumulation of AGEs and upregulated expression of RAGE is associated with various pathological conditions including diabetes, cardiovascular diseases, neurodegenerative disorders, and cancer. The role of AGE-RAGE signaling has been demonstrated in the progression of various types of cancer and other pathological disorders. The expression of RAGE increases manifold during cancer progression. The activation of AGE-RAGE signaling also perturbs the cellular redox balance and modulates various cell death pathways. The programmed cell death signaling often altered during the progression of malignancies. The cellular reprogramming of AGE-RAGE signaling with cell death machinery during tumorigenesis is interesting to understand the complex signaling mechanism of cancer cells. The present review focus on multiple molecular paradigms relevant to cell death particularly Apoptosis, Autophagy, and Necroptosis that are considerably influenced by the AGE-RAGE signaling in the cancer cells. Furthermore, the review also attempts to shed light on the provenience of AGE-RAGE signaling on oxidative stress and consequences of cell survival mechanism of cancer cells.
引用
收藏
页码:585 / 598
页数:14
相关论文
共 147 条
  • [1] Toll-like receptor signalling
    Akira, S
    Takeda, K
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 499 - 511
  • [2] The dark side of radiotherapy-induced cell death in cancer
    Alcala, Sonia
    Sainz, Bruno, Jr.
    [J]. EBIOMEDICINE, 2019, 40 : 7 - 8
  • [3] Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor
    Alikhani, Mani
    MacLellan, Christine M.
    Raptis, Markos
    Vora, Siddarth
    Trackman, Philip C.
    Graves, Dana T.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 292 (02): : C850 - C856
  • [4] Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways
    Alikhani, Mani
    Alikhani, Zoubin
    Boyd, Coy
    MacLellan, Christine M.
    Raptis, Markos
    Liu, Rongkun
    Pischon, Nicole
    Trackman, Philip C.
    Gerstenfeld, Louis
    Graves, Dana T.
    [J]. BONE, 2007, 40 (02) : 345 - 353
  • [5] Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways
    Alikhani, ZB
    Alikhani, M
    Boyd, CM
    Nagao, K
    Trackman, PC
    Graves, DT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (13) : 12087 - 12095
  • [6] MicroRNA functions in animal development and human disease
    Alvarez-Garcia, I
    Miska, EA
    [J]. DEVELOPMENT, 2005, 132 (21): : 4653 - 4662
  • [7] The functions of animal microRNAs
    Ambros, V
    [J]. NATURE, 2004, 431 (7006) : 350 - 355
  • [8] S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
    Arumugam, Thiruvengadam
    Ramachandran, Vijaya
    Gomez, Sobeyda B.
    Schmidt, Ann M.
    Logsdon, Craig D.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4356 - 4364
  • [9] Barlovic Drazenka P., 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P7
  • [10] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29